CN101843825B - Chinese medicament for treating climacteric syndromes - Google Patents

Chinese medicament for treating climacteric syndromes Download PDF

Info

Publication number
CN101843825B
CN101843825B CN2009102358725A CN200910235872A CN101843825B CN 101843825 B CN101843825 B CN 101843825B CN 2009102358725 A CN2009102358725 A CN 2009102358725A CN 200910235872 A CN200910235872 A CN 200910235872A CN 101843825 B CN101843825 B CN 101843825B
Authority
CN
China
Prior art keywords
radix
chinese
parts
chinese medicine
fine powder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN2009102358725A
Other languages
Chinese (zh)
Other versions
CN101843825A (en
Inventor
刘新壮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Qidong Tianfen Electric Tool Technology Innovation Center
Original Assignee
Lvyuan Qiuzheng Technology Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lvyuan Qiuzheng Technology Development Co Ltd filed Critical Lvyuan Qiuzheng Technology Development Co Ltd
Priority to CN2009102358725A priority Critical patent/CN101843825B/en
Publication of CN101843825A publication Critical patent/CN101843825A/en
Application granted granted Critical
Publication of CN101843825B publication Critical patent/CN101843825B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a Chinese medicament for treating climacteric syndromes, and belongs to the field of Chinese medicaments for treating gynecopathy. The invention aims to provide the Chinese medicament with good effect and quick response. The Chinese medicament is prepared from the following raw materials: anemarrhena asphodeloides bunge, fresh rehmannia root, medicinal indianmulberry root, amur corktree bark, lucid ganoderma, radix pseudo-ginseng, Chinese angelica, Chinese wolfberry and the like. The Chinese medicament has the effects of strengthening body resistance and banking up root, tonifying qi and nourishing blood, activating blood and dissolving stasis, nourishing kidney and liver, and clearing internal heat, and has the advantages of obvious effect, exact medicinal effect and quick response.

Description

A kind of Chinese medicine for the treatment of climacteric syndrome
Technical field
The invention belongs to the gynopathic field of Chinese medicines of treatment.
Background technology
Before and after the menopausal women, be main symptom, be referred to as climacteric syndrome owing to a series of autonomic nervous system disorders appear in the ovarian function decline.The present Chinese medicine aspect that is intended to treat climacteric syndrome, exist the deficiency of two aspects: the one, effect is obvious inadequately, and the 2nd, it is slower to take effect, to such an extent as to large quantities of climacteric women is owing to can not get the treatment of active drug, be subjected to ailing torment---warm perspiration for a long time, flushing hectic fever, vertigo and tinnitus, irritated irritability, insomnia, even the limbs edema, the frequent micturition incontinence has had a strong impact on quality of life.Patient and family members thereof are very dissatisfied.
At problem set forth above, the invention provides a kind of Chinese medicine for the treatment of climacteric syndrome, it can solve, and this type of Chinese medicine effect was obvious inadequately in the past, the slower problem that takes effect, effective, instant effect, it is remarkable to have effect, drug effect is definite, the advantage of quick result.
Summary of the invention
The present invention is achieved through the following technical solutions:
A kind of Chinese medicine for the treatment of climacteric syndrome adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Rhizoma Anemarrhenae 4-30 part Radix Rehmanniae 4-30 part Radix Morindae Officinalis 4-30 part
Cortex Phellodendri 3-20 part Ganoderma 2-12 part Radix Notoginseng 3-20 part
Radix Angelicae Sinensis 4-30 part Fructus Lycii 4-30 part
The Chinese medicine of this treatment climacteric syndrome is made by following method:
(1) by above-mentioned weight ratio, the Rhizoma Anemarrhenae, Radix Rehmanniae, Radix Morindae Officinalis, Cortex Phellodendri, Radix Angelicae Sinensis, Fructus Lycii are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, can be made into Chinese medicine electuary, granule, powder, capsule, watered pill, tablets and other formulations.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.The traditional Chinese medical science thinks that deficiency of the kidney yin is the basic cause of disease of climacteric syndrome, controls suitable nourishing the kidney and liver, clear eliminating heart-fire.Radix Rehmanniae, the Rhizoma Anemarrhenae nourish kidney yin in the side; The Fructus Lycii nourishing the liver and kidney; Compatibility Radix Morindae Officinalis warming and recuperating the kidney-YANG is intended to treating YIN within YANG; Close with the Ganoderma benefiting QI and nourishing blood tranquilizing by nourishing the heart, the body resistance strengthening and constitution consolidating, enhancing human body immunity power; Radix Angelicae Sinensis, Radix Notoginseng nourshing blood and promoting blood circulation, blood circulation promoting and blood stasis dispelling; Assistant is with the Cortex Phellodendri clearing away heat-fire.All medicine compatibilities bring out the best in each other, and play the body resistance strengthening and constitution consolidating altogether, benefiting QI and nourishing blood, and blood circulation promoting and blood stasis dispelling, nourishing the kidney and liver, the merit of clear eliminating heart-fire, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
The specific embodiment
By following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
The Rhizoma Anemarrhenae 80 gram Radix Rehmanniae 80 gram Radix Morindae Officinaliss 80 grams
Cortex Phellodendri 60 kairine sesames 40 gram Radix Notoginseng 60 grams
Radix Angelicae Sinensis 80 gram Fructus Lyciis 80 grams
Weight in accordance with regulations, with conventional water extraction process the Rhizoma Anemarrhenae, Radix Rehmanniae, Radix Morindae Officinalis, Cortex Phellodendri, Radix Angelicae Sinensis, Fructus Lycii are extracted, make extractum fine powder 138 grams, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder, make fine particle, the capsule of packing into No. 0 is made 850 of Chinese medicinal capsules, and every capsules includes Chinese medicine fine powder and extract 0.28 gram.
2, get following prescription (weight is unit by gram):
The Rhizoma Anemarrhenae 160 gram Radix Rehmanniae 160 gram Radix Morindae Officinaliss 160 grams
Cortex Phellodendri 100 kairine sesames 60 gram Radix Notoginseng 100 grams
Radix Angelicae Sinensis 160 gram Fructus Lyciis 160 grams
By above-mentioned same method, make 1535 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
3, get following prescription (weight is unit by gram):
The Rhizoma Anemarrhenae 300 gram Radix Rehmanniae 300 gram Radix Morindae Officinaliss 300 grams
Cortex Phellodendri 200 kairine sesames 120 gram Radix Notoginseng 200 grams
Radix Angelicae Sinensis 300 gram Fructus Lyciis 300 grams
By above-mentioned same method, make 2964 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
4, get following prescription (by weight):
7 parts of 7 parts of Radix Morindae Officinaliss of 7 parts of Radix Rehmanniae of the Rhizoma Anemarrhenae
5 parts of 4 portions of Radix Notoginseng of 5 portions of Ganodermas of Cortex Phellodendri
7 parts of 7 portions of Fructus Lyciis of Radix Angelicae Sinensis
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
5, get following prescription (by weight):
20 parts of 20 parts of Radix Morindae Officinaliss of 20 parts of Radix Rehmanniae of the Rhizoma Anemarrhenae
15 parts of 8 portions of Radix Notoginseng of 12 portions of Ganodermas of Cortex Phellodendri
20 parts of 20 portions of Fructus Lyciis of Radix Angelicae Sinensis
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
Clinical data:
The present invention is an example with traditional Chinese medical science climacteric syndrome, through 8 routine clinical observations.Selecting the tcm diagnosis climacteric syndrome is standard: the middle-aged women menoxenia, and vertigo and tinnitus is warmed perspiration, flushing hectic fever, easy dry irritability, it is weak to have a sleepless night etc.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, be the women all, there is not other serious disease, the age is 47 years old-52 years old, 49.3 years old mean age.
Efficacy determination:
1, produce effects: insomnia, weak alleviation or disappearance, warm sweating, flushing hectic fever, easy dry irritability and obviously alleviate.
2, effective: insomnia, weak, warm symptom such as sweating and alleviate to some extent.
3, invalid: the disease no change.
During clinical experiment, withdraw other medicines and health nutrient.Taking Chinese medicinal capsule of the present invention, observed 3 months, is a course of treatment.Instructions of taking: every day 3 times, each 4 capsules, every capsules include Chinese medicine fine powder and extract 0.28 gram, warm water delivery service after meal, symptom promptly has alleviation after 1 month, take 3 months after, symptom is obviously improved.8 philtrums of clinical experiment, produce effects 4 people, effective 3 people, invalid 1 people, total effective rate 87.5%.

Claims (1)

1. a Chinese medicine for the treatment of climacteric syndrome adopts the raw material of Chinese medicine preparation, and it is characterized in that: it is to make with the component of following weight ratio:
The Rhizoma Anemarrhenae 4---30 parts of 30 parts of Radix Rehmanniae 4---30 parts of Radix Morindae Officinaliss 4---
Cortex Phellodendri 3---20 parts of 20 portions of Ganodermas 2---12 portions of Radix Notoginseng 3---
30 parts of Radix Angelicae Sinensis 4---30 portions of Fructus Lyciis 4---
The Chinese medicine of this treatment climacteric syndrome is made by following method:
(1) by above-mentioned weight ratio, the Rhizoma Anemarrhenae, Radix Rehmanniae, Radix Morindae Officinalis, Cortex Phellodendri, Radix Angelicae Sinensis, Fructus Lycii are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, make Chinese medicine granules, powder, capsule, watered pill, Tabules.
CN2009102358725A 2009-10-28 2009-10-28 Chinese medicament for treating climacteric syndromes Active CN101843825B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2009102358725A CN101843825B (en) 2009-10-28 2009-10-28 Chinese medicament for treating climacteric syndromes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2009102358725A CN101843825B (en) 2009-10-28 2009-10-28 Chinese medicament for treating climacteric syndromes

Publications (2)

Publication Number Publication Date
CN101843825A CN101843825A (en) 2010-09-29
CN101843825B true CN101843825B (en) 2011-08-24

Family

ID=42768763

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009102358725A Active CN101843825B (en) 2009-10-28 2009-10-28 Chinese medicament for treating climacteric syndromes

Country Status (1)

Country Link
CN (1) CN101843825B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102349986B (en) * 2011-10-01 2013-07-10 张志红 Traditional Chinese medicine for treating climacteric syndrome

Also Published As

Publication number Publication date
CN101843825A (en) 2010-09-29

Similar Documents

Publication Publication Date Title
CN101843694B (en) Chinese medicament for treating chronic hepatitis
CN102139049A (en) Traditional Chinese medicine for treating diabetic skin pruritus
CN101843828A (en) Chinese medicament for treating climacteric syndromes
CN101972422A (en) Traditional Chinese medicine for treating diabetic pruritus
CN101850071B (en) Chinese medicament for treating chronic nephritis
CN101843740B (en) Chinese medicament for treating climacteric syndromes
CN101843825B (en) Chinese medicament for treating climacteric syndromes
CN101843709B (en) Chinese medicament for treating abnormal menstruation
CN101843778B (en) Chinese medicament for treating ichthyosis
CN101843678B (en) Chinese medicament for treating climacteric syndromes
CN101843693A (en) Chinese medicament for treating diabetic nephropathy
CN101843734B (en) Chinese medicament for treating abnormal menstruation
CN102397336A (en) Traditional Chinese medicine used for treating diabetic pruritus
CN101850021B (en) Chinese medicament for treating abnormal menstruation
CN101843718B (en) Chinese medicament for treating lupus erythematosus
CN101843768B (en) Chinese medicament for treating climacteric syndromes
CN101843707B (en) Chinese medicament for treating chronic hepatitis
CN101843705B (en) Chinese medicament for treating lupus erythematosus
CN101843806B (en) Chinese medicament for treating climacteric syndromes
CN101843775A (en) Chinese medicament for treating diabetic nephropathy
CN101843704A (en) Chinese medicament for treating chronic hepatitis
CN101843722B (en) Chinese medicament for treating ichthyosis
CN101843711B (en) Chinese medicament for treating ichthyosis
CN101843745B (en) Chinese medicament for treating chronic hepatitis
CN101843771B (en) Chinese medicament for treating ichthyosis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: QIDONG TIANFEN ELECTRIC TOOL TECHNOLOGY INNOVATION

Free format text: FORMER OWNER: BEIJING LVYUANQIUZHENG TECHNOLOGY DEVELOPMENT CO., LTD.

Effective date: 20141125

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 100040 SHIJINGSHAN, BEIJING TO: 226241 NANTONG, JIANGSU PROVINCE

TR01 Transfer of patent right

Effective date of registration: 20141125

Address after: Qidong City, Jiangsu province 226241 Nantong lvsigang Tianfen electric tools trade city comprehensive building

Patentee after: Qidong Tianfen Electric Tool Technology Innovation Center

Address before: 100040 Beijing city Shijingshan District street Babaoshan Lugu Village District No. 7 building 10-602 room

Patentee before: Beijing Lvyuanqiuzheng Technology Development Co., Ltd.